Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Fever of Unknown Origin D005335 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Psittacosis D009956 4 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Urethral Diseases D014522 4 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Superinfection D015163 3 associated lipids
Otitis Media, Suppurative D010035 4 associated lipids
Serum Sickness D012713 7 associated lipids
Bites, Human D001734 2 associated lipids
Rickettsia Infections D012282 5 associated lipids
Pharyngeal Diseases D010608 4 associated lipids
Granuloma Inguinale D006100 2 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Elephantiasis, Filarial D004605 4 associated lipids
Hearing Loss, Conductive D006314 2 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Bartonella Infections D001474 3 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Dry Socket D004368 3 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Furunculosis D005667 2 associated lipids
Elephantiasis D004604 2 associated lipids
Lymphangitis D008205 4 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Herpes Genitalis D006558 2 associated lipids
Pericoronitis D010497 2 associated lipids
Tuberculosis, Urogenital D014401 2 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Abdominal Abscess D018784 2 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Hoarseness D006685 2 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Toxoplasmosis, Ocular D014126 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Acquired Hyperostosis Syndrome D020083 1 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Syncope, Vasovagal D019462 1 associated lipids
Leishmaniasis, Mucocutaneous D007897 1 associated lipids
Trichiasis D058457 1 associated lipids
Paratyphoid Fever D010284 1 associated lipids
Ectodermal Dysplasia D004476 1 associated lipids
Tooth Erosion D014077 2 associated lipids
Epiglottitis D004826 1 associated lipids
Furcation Defects D017823 1 associated lipids
Pseudolymphoma D019310 1 associated lipids
Tenosynovitis D013717 3 associated lipids
Corneal Endothelial Cell Loss D055954 1 associated lipids
Asymptomatic Infections D058345 1 associated lipids
Aphasia, Broca D001039 1 associated lipids
Heartburn D006356 2 associated lipids
Eisenmenger Complex D004541 1 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Splenic Diseases D013158 5 associated lipids
Trismus D014313 1 associated lipids
Male Urogenital Diseases D052801 1 associated lipids
Hyper-IgM Immunodeficiency Syndrome D053306 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Pyomyositis D052880 2 associated lipids
Myelitis, Transverse D009188 1 associated lipids
Hernia, Hiatal D006551 3 associated lipids
Achondroplasia D000130 1 associated lipids
Tracheobronchomalacia D055089 1 associated lipids
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Voytilla KL et al. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. 2002 Am J Health Syst Pharm pmid:12004465
Chahine C et al. Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. 2001 Am J Health Syst Pharm pmid:11596697
Goldstein RC et al. Fluoroquinolone- and ceftriaxone-based therapy of community-acquired pneumonia in hospitalized patients: the risk of subsequent isolation of multidrug-resistant organisms. 2014 Am J Infect Control pmid:24773792
Sorvillo F et al. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. 2001 Am J Infect Control pmid:11287873
Lilley LL and Guanci R Distraction delays a dose. 1998 Am J Nurs pmid:9473978
Hashisaki GT Update on macrolide antibiotics. 1995 May-Jun Am J Otolaryngol pmid:7661309
Marple BF et al. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis. 2010 Jan-Feb Am J Otolaryngol pmid:19944891
El Hennawi DED et al. Management of recurrent tonsillitis in children. Am J Otolaryngol pmid:28385329
Klapan I et al. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. 1999 Jan-Feb Am J Otolaryngol pmid:9950107
Mvundura E et al. Good pregnancy outcome with emergent cerclage placed in the presence of intra-amniotic microbial invasion. 2007 Am J Perinatol pmid:17597442
Crum NF et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. 2003 Am J Prev Med pmid:12880877
Wolter JM et al. Macrolides in cystic fibrosis: is there a role? 2002 Am J Respir Med pmid:14720043
Margaritis VK et al. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis. 2007 Sep-Oct Am J Rhinol pmid:17999793
Maniakas A and Desrosiers M Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit. Am J Rhinol Allergy pmid:24598145
Amali A et al. Long-term postoperative azithromycin in patients with chronic rhinosinusitis: A randomized clinical trial. Am J Rhinol Allergy pmid:26637580
Bin Abdulhak AA et al. Azithromycin and Risk of Cardiovascular Death: A Meta-Analytic Review of Observational Studies. Am J Ther pmid:25748818
Sutera L et al. Azithromycin in an older woman with diabetic gastroparesis. 2008 Jan-Feb Am J Ther pmid:18223358
Muhlestein JB Animal models of chlamydia and atherosclerosis. 1999 Am. Heart J. pmid:10539862
Gupta S Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease. 1999 Am. Heart J. pmid:10539869
Dunne M WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. 1999 Am. Heart J. pmid:10539870
Grayston JT Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis. 1999 Am. Heart J. pmid:10539875
Hillis GS et al. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. 2004 Am. Heart J. pmid:15215794
Gabrielli M et al. Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome. 2005 Am. Heart J. pmid:16084141
Schneider CA et al. In vivo uptake of azithromycin in human coronary plaques. 2000 Am. J. Cardiol. pmid:11018204
Kuvin JT et al. Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. 2003 Am. J. Cardiol. pmid:12633811
Hyodo E et al. Effect of azithromycin therapy on coronary circulation in patients with coronary artery disease. 2004 Am. J. Cardiol. pmid:15566918
Lin L et al. A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS. 2003 Am. J. Chin. Med. pmid:14992536
Choi AH et al. Clinicocytopathologic correlation in an atypical presentation of lymphadenopathy with review of literature. 2015 Am. J. Clin. Pathol. pmid:25873511
Sadatsafavi M et al. The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. 2016 Am. J. Epidemiol. pmid:27737842
Koukounari A et al. Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma. 2013 Am. J. Epidemiol. pmid:23548755
Bertoni G et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. 1996 Am. J. Gastroenterol. pmid:8607489
Di Mario F et al. Azithromycin for the cure of Helicobacter pylori infection. 1996 Am. J. Gastroenterol. pmid:8607490
Tursi A et al. The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. 1996 Am. J. Gastroenterol. pmid:8677967
Sullivan B et al. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. 2002 Am. J. Gastroenterol. pmid:12385435
Trevisani L et al. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. 1998 Am. J. Gastroenterol. pmid:9517646
al-Assi MT et al. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. 1995 Am. J. Gastroenterol. pmid:7872278
Laine L et al. Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. 1999 Am. J. Gastroenterol. pmid:10201465
Mendu ML and Waikar SS Drug-drug interactions and acute kidney injury: caveat prescriptor. 2014 Am. J. Kidney Dis. pmid:24820318
Hung AM and Hakim RM Dialysate and serum potassium in hemodialysis. 2015 Am. J. Kidney Dis. pmid:25828570
Longo G et al. Azithromycin-induced intrahepatic cholestasis. 1997 Am. J. Med. pmid:9217574
Hong BK et al. "MAC" attack. 2009 Am. J. Med. pmid:19958886
Cameron DJ Effectiveness of early Lyme disease treatment. 1993 Am. J. Med. pmid:8388627
Massarotti EM et al. Treatment of early Lyme disease. 1992 Am. J. Med. pmid:1313637
Cascaval RI and Lancaster DJ Hypersensitivity syndrome associated with azithromycin. 2001 Am. J. Med. pmid:11247598
Sheth A et al. The traveling farm wife. 2007 Am. J. Med. pmid:17208072
Moellering RC Introduction: revolutionary changes in the macrolide and azalide antibiotics. 1991 Am. J. Med. pmid:1656735
Neu HC Clinical microbiology of azithromycin. 1991 Am. J. Med. pmid:1656736
Stamm WE Azithromycin in the treatment of uncomplicated genital chlamydial infections. 1991 Am. J. Med. pmid:1656737
Hooton TM A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. 1991 Am. J. Med. pmid:1656738
Casiano RR Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. 1991 Am. J. Med. pmid:1656739
Dark D Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. 1991 Am. J. Med. pmid:1656740
Mallory SB Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. 1991 Am. J. Med. pmid:1656741
Hopkins S Clinical toleration and safety of azithromycin. 1991 Am. J. Med. pmid:1656742
Schentag JJ and Ballow CH Tissue-directed pharmacokinetics. 1991 Am. J. Med. pmid:1656743
Taylor SP et al. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly. 2015 Am. J. Med. pmid:26291905
Baciewicz AM et al. Azithromycin-induced hepatoxicity. 2005 Am. J. Med. pmid:16378809
Missov E and Cogswell R Sudden cardiac death, mitral valve prolapse, and long QT syndrome. 2015 Am. J. Med. pmid:26071830
Winton JC and Twilla JD Sudden cardiac arrest in a patient on chronic methadone after the addition of azithromycin. 2013 Am. J. Med. Sci. pmid:23103438
Devasia RA et al. Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak. 2009 Am. J. Med. Sci. pmid:19301451
Sutton AL et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. 2015 Am. J. Obstet. Gynecol. pmid:25595580
Andrews WW et al. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. 2006 Am. J. Obstet. Gynecol. pmid:16522388
Jacobson GF et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. 2001 Am. J. Obstet. Gynecol. pmid:11408852
Tita AT et al. Impact of interconception antibiotics on the endometrial microbial flora. 2007 Am. J. Obstet. Gynecol. pmid:17346530
Grigsby PL et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. 2012 Am. J. Obstet. Gynecol. pmid:23111115
Ward E and Duff P A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study. 2016 Am. J. Obstet. Gynecol. pmid:26901276
Gray RH et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. 2001 Am. J. Obstet. Gynecol. pmid:11717659
Ramsey PS et al. Maternal and transplacental pharmacokinetics of azithromycin. 2003 Am. J. Obstet. Gynecol. pmid:12634646
Lin KJ et al. Safety of macrolides during pregnancy. 2013 Am. J. Obstet. Gynecol. pmid:23254249
Tita AT et al. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. 2008 Am. J. Obstet. Gynecol. pmid:18771992
Johnson RB The role of azalide antibiotics in the treatment of Chlamydia. 1991 Am. J. Obstet. Gynecol. pmid:1645503
Kelsey JJ et al. Presence of azithromycin breast milk concentrations: a case report. 1994 Am. J. Obstet. Gynecol. pmid:8178871
Keelan JA et al. Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep. 2011 Am. J. Obstet. Gynecol. pmid:21481833
Tita AT et al. Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction. 2007 Am. J. Obstet. Gynecol. pmid:17904962
Uy HS et al. Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome. 1999 Am. J. Ophthalmol. pmid:10030567
Kuehne JJ et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. 2004 Am. J. Ophthalmol. pmid:15488779
Bosch-Driessen LH et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. 2002 Am. J. Ophthalmol. pmid:12095805
Stewart WC et al. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. 2010 Am. J. Ophthalmol. pmid:20813346
Wolle MA et al. Impact of Trichiasis surgery on physical functioning in Ethiopian patients: STAR trial. 2011 Am. J. Ophthalmol. pmid:21333268
Katusic D et al. Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. 2003 Am. J. Ophthalmol. pmid:12654359
Abelson MB et al. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. 2008 Am. J. Ophthalmol. pmid:18374301
Ness PJ et al. An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin. 2010 Am. J. Ophthalmol. pmid:20678751
Fan LC et al. Macrolides protect against infection via inhibition of inflammasomes. 2017 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:28684545
Shinkai M et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16085674
Blau H et al. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17012372
Tarran R et al. Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. 2013 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23542952
Kadova Z et al. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. 2015 Am. J. Physiol. Renal Physiol. pmid:25503728
Meyer M et al. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19244203
Halldorsson S et al. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. 2010 Am. J. Respir. Cell Mol. Biol. pmid:19372247
Bergamini G et al. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19097986
Verleden GM et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. 2006 Am. J. Respir. Crit. Care Med. pmid:16741151
Williams TJ and Verleden GM Azithromycin: a plea for multicenter randomized studies in lung transplantation. 2005 Am. J. Respir. Crit. Care Med. pmid:16148194
Barker PM et al. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. 2005 Am. J. Respir. Crit. Care Med. pmid:15657462
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Kunisaki KM et al. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. 2012 Am. J. Respir. Crit. Care Med. pmid:22077070
Restrepo MI and Anzueto A Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet? 2014 Am. J. Respir. Crit. Care Med. pmid:24983214
Lococo F et al. Hemoptysis and Progressive Dyspnea in a 67-Year-Old Woman with History of Renal Transplantation. 2016 Am. J. Respir. Crit. Care Med. pmid:26681504
Yates B et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. 2005 Am. J. Respir. Crit. Care Med. pmid:15976371
Albert RK and Schuller JL Macrolide antibiotics and the risk of cardiac arrhythmias. 2014 Am. J. Respir. Crit. Care Med. pmid:24707986
Han MK et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. 2014 Am. J. Respir. Crit. Care Med. pmid:24779680